Fueled at least in part by exceptionally strong IPO and M&A markets, hedge funds, venture capitalists, private equity firms and corporate investors are committing more time and money into privately held medical devices companies, according to a new “Healthcare Investments and Exits” report issued by Silicon Valley Bank. The report examining the first half of […]
Funding Roundup
Ancora Heart raises $80M for ventricular restoration system
Ancora Heart announced today that it raised $80 million in equity financing for its AccuCinch ventricular restoration system. Santa Clara, Calif.–based Ancora Heart said in a news release that funds raised in the equity round are earmarked for the acceleration of the Corcinch-HF pivotal clinical study of the AccuCinch system for treating symptomatic heart failure […]
MedTech 100 roundup: Industry shatters all-time best with remarkable rise
The medtech industry’s steady growth provided optimism in recent weeks, but an unforeseen leap sees it hitting new heights now. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 16) at 145.88 points, a remarkable 27.1% rise week-over-week, registering by far the greatest increase the […]
HeartFlow to go public in $2.8B SPAC merger
HeartFlow today said that it will go public by merging with a SPAC called Longview Acquisition Corp. The merger is valued at $2.4 billion plus an estimated $400 million in cash after closing. The transaction is expected to deliver up to $599 million of gross proceeds to HeartFlow to accelerate the growth of its noninvasive, […]
Imperative Care raises $260M Series D for stroke care tech, acquires Truvic Medical
Imperative Care announced today that it closed a $260 million Series D financing round to support its stroke care technologies. Campbell, Calif.-based Imperative Care had its funding led by D1 Capital Partners, with new investors HealthCor Investments and Innovatus Capital Partners also joining the round. In addition, existing investors Ally Bridge Group, Bain Capital Life […]
Lumos Diagnostics raises $46.8M in Australian IPO
Lumos Diagnostics announced today that it raised $46.8 million ($63 million AUD) in an initial public offering in Australia. Sarasota, Fla.-based Lumos (which has its corporate head offices in Melbourne, Australia), a fully integrated developer and manufacturer of custom point-of-care diagnostic tests, was admitted to the Australian Securities Exchange (ASX) with trading commencing after July […]
Osso VR raises $27M for its immersive surgical training
Osso VR announced today that it has raised $27 million in a Series B round as it seeks to fuel further growth around its virtual reality surgical training and assessment platform. GSR Ventures led the round, with participation from Signalfire, Kaiser Permanente Ventures, OCA Ventures, Scrum Ventures, Leslie Ventures and Anorak Ventures. San Francisco–based Osso […]
MedTech 100 roundup: New all-time best reached
Once again, the medtech industry has soared to new heights, eclipsing its all-time best performance by the tiniest of margins. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the week (July 2) at 114.59 points. It was just 0.01 points ahead of the 114.58-point mark set in […]
EchoNous raises $60M for AI-guided ultrasound
EchoNous announced that it raised $60 million to launch its flagship AI-guided Kosmos ultrasound device. Redmond, Wash.-based EchoNous received the investment from Kennedy Lewis Investment Management, with the funding combining senior secured debt and equity to build on the support of KKR, EchoNous’ principal investor since 2015, according to a news release. The company said […]
NeuroPace wins five-year $9.3M grant from NIH
NeuroPace today announced that it has received a $9.3 million National Institutes of Health grant to study Lennox-Gastaut Syndrome treatment. The NIH — through the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative — will provide up to $9.3 million over a five-year period to evaluate the use of Mountain View, Calif.-based NeuroPace’s RNS neuromodulation […]
Giiant Pharma extends seed round with $1.25M
Giiant Pharma announced today that it added $1.25 million to its seed financing round to ensure reaching clinical proof-of-concept for its Precision Delivery technology platform. Montreal-based Giiant’s $750,000 in funding from AQC Capital, plus $500,000 from CQDM, adds to the seed round closed last month to bring the company’s total funding to nearly $15 million. Get the […]
